Ripk1 and haematopoiesis: a case for LUBAC and Ripk3

Cell Death Differ. 2018 Aug;25(8):1361-1363. doi: 10.1038/s41418-018-0135-2.

Authors

Alessandro Annibaldi¹, Pascal Meier²

Affiliations

¹ The Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, Fulham Road, London, SW3 6JB, UK.
² The Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, Fulham Road, London, SW3 6JB, UK. pmeier@icr.ac.uk.

No abstract available

Publication types

Comment

MeSH terms

Hematopoiesis
Receptor-Interacting Protein Serine-Threonine Kinases
Receptors, Tumor Necrosis Factor, Type I*
Ubiquitin*

Substances

Receptors, Tumor Necrosis Factor, Type I
Ubiquitin
Receptor-Interacting Protein Serine-Threonine Kinases

Grants and funding

MR/M019217/1/MRC_/Medical Research Council/United Kingdom